A compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9 and n are as defined in the description, its optical isomers, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal product containing the same for treating a mammal afflicted with a disorder connected with peroxydation processes and biosynthesis of eicosanoids.
从以下
化学式(I)中选择的化合物:##STR1## 其中R.sub.1,R.sub.2,R.sub.3,R.sub.4,R.sub.5,R.sub.6,R.sub.7,R.sub.8,R.sub.9和n如描述中所定义,其光学异构体及其与药学上可接受的酸或碱形成的加合物盐,以及含有该化合物的药物产品,用于治疗患有与过氧化作用过程和
前列腺素生物合成相关的疾病的哺乳动物。